Results 91 to 100 of about 24,468 (197)

Depot medroxyprogesterone acetate (DMPA)-associated early-onset osteoporotic fracture

Endocrinology, Diabetes & Metabolism Case Reports
Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive, but is associated with reduced bone mineral density (BMD) and increased fracture risk in some studies because it inhibits the hypothalamic–pituitary–ovarian axis ...
Yotsapon Thewjitcharoen, Veekij Veerasomboonsin, Soontaree Nakasatien, Thep Himathongkam   +3 more
doaj   +1 more source

Protective Effect of Vitamins C and E on Depot-Medroxyprogesterone Acetate-Induced Ovarian Oxidative Stress In Vivo

Journal of Toxicology, 2016
A study was designed to investigate ameliorates effect of combined vitamins C and E able to against depot-medroxyprogesterone acetate- (DMPA-) induced ovarian oxidative stress in rat. Twenty-five female Wistar rats were divided into the following groups (
Atik Ismiyati, I. Wayan Arsana Wiyasa, Dwi Yuni Nur Hidayati   +2 more
doaj   +1 more source

Perbedaan Profil Lipid pada Akseptor Depo Medroksi Progesteron Asetat dengan Implant Levonorgestrel di Wilayah Kerja Puskesmas Air Tawar Padang Tahun 2014

Jurnal Kesehatan Andalas, 2015
AbstrakDepo Medroksiprogesteron Asetat dan Implant Levonorgestrel merupakan kontrasepsi hormonal progestin sintetik yang memiliki efek samping yaitu peningkatan berat badan dan mempengaruhi metabolisme lipid. Tujuan penelitian ini adalah untuk mengetahui
Rafika Oktova, Desmiwarti ., Arni Amir
doaj  

Injectable Contraceptive Use in Women With Intellectual Disability – A Narrative Review and Local Case Series

BJPsych Open
Aims: Intellectual Disability is defined as an IQ below 71. People with intellectual disability frequently experience menstrual distress leading to use of hormonal medications such as depot medroxyprogesterone acetate (DMPA).
Marianne Bergman, Alaa Martin
doaj   +1 more source

Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.

Contraception, 2017
J. Brooks, David J Edwards, Diana L. Blithe, Jennifer M. Fettweis, Myrna G. Serrano, N. Sheth, J. F. Strauss, Gregory A. Buck, K. Jefferson   +8 more
semanticscholar   +1 more source

The pregnancy outcome of progestin‐primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial

BJOG: an International Journal of Obstetrics and Gynaecology, 2017
J. Dong, Yu Wang, W. Chai, Q. Hong, Ningling Wang, Lihua Sun, Hui Long, Li Wang, Hui Tian, Q. Lyu, Xuefeng Lu, Qj Chen, Y. Kuang   +12 more
semanticscholar   +1 more source

Medroxyprogesterone [PDF]

Reactions Weekly, 2020
  +4 more sources

Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.

Fertility and Sterility, 2015
Y. Kuang, Qiuju Chen, Yonglun Fu, Yun Wang, Q. Hong, Q. Lyu, A. Ai, Z. Shoham   +7 more
semanticscholar   +1 more source

Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.

Annals of Oncology, 2016
Akira Mitsuhashi, Yasunori Sato, T. Kiyokawa, M. Koshizaka, Hideki Hanaoka, Makio Shozu   +5 more
semanticscholar   +1 more source

Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections

International Journal of General Medicine, 2011
L Amanti2, H Sadeghi-Bazargani1, H Abdollahi2, F Ehdaeivand31Statistics and Epidemiology Department, Faculty of Health and Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran; 2Tabriz University of Medical Sciences, Tabriz, Iran; 3Faculty of ...
Amanati L, Sadeghi-Bazargani H, Abdollahi H, Ehdaeiv, F   +4 more
doaj